Gary D. Tollefson, President and CEO at Orexigen Therapeutics, Inc. (OREX), sold 14,600 shares at $15.82 ($229K) on 2007-11-15, disclosed to the SEC on 2007-11-16.
Scheduled sale ($229k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.45 | 900 | $14K | 6.1% |
| 2 | $15.45 | 100 | $2K | 0.7% |
| 3 | $15.50 | 48 | $744 | 0.3% |
| 4 | $15.50 | 3,900 | $60K | 26.4% |
| 5 | $15.50 | 100 | $2K | 0.7% |
| 6 | $15.50 | 661 |
| $10K |
| 4.5% |
| 7 | $15.51 | 600 | $9K | 4.1% |
| 8 | $15.51 | 91 | $1K | 0.6% |
| 9 | $15.51 | 100 | $2K | 0.7% |
| 10 | $15.75 | 900 | $14K | 6.2% |
| 11 | $15.75 | 100 | $2K | 0.7% |
| 12 | $15.82 | 5,000 | $79K | 34.5% |
| 13 | $15.90 | 172 | $3K | 1.2% |
| 14 | $15.90 | 900 | $14K | 6.2% |
| 15 | $15.90 | 100 | $2K | 0.7% |
| 16 | $15.91 | 528 | $8K | 3.7% |
| 17 | $15.91 | 100 | $2K | 0.7% |
| 18 | $15.95 | 300 | $5K | 2.1% |
| Total | $15.68 avg | 14,600 | $229K | 100% |
| Filing → |